Home › Funds › Boxer Capital Management, LLC › CTNM

Boxer Capital Management, LLC position in CTNM

CONTINEUM THERAPEUTICS INC CL A · Health Care

Boxer Capital Management, LLC reported holding 494,000 shares of CTNM (CONTINEUM THERAPEUTICS INC CL A) in its Q2 2026 13F filing — a position valued at US$8.1M, representing 0.61% of its reported portfolio and ranking #32 among its reported holdings. Boxer Capital Management, LLC has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)494.00K sh
Reported value held$8.10M
Portfolio Weight0.61%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's CTNM position evolved

Boxer Capital Management, LLC first disclosed a stake in CTNM in Q4 2025 at 494,000 shares (US$5.6M). The position peaked in Q2 2026 at 494,000 shares, worth US$8.1M. Across 3 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 494,000 shares valued at US$8.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 494.00K $5.65M New
Q1 2026 494.00K $6.45M Hold
Q2 2026 494.00K $8.10M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTNM and 13F data

CTNM (CONTINEUM THERAPEUTICS INC CL A) is a Health Care company. 63 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$32.4M), GREAT POINT PARTNERS LLC (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTNM

All CTNM fund holders →

FAQ

How long has Boxer Capital Management, LLC held CTNM?

Boxer Capital Management, LLC has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Boxer Capital Management, LLC's current position in CTNM?

As of Q2 2026, Boxer Capital Management, LLC holds 494.00K shares of CTNM (CONTINEUM THERAPEUTICS INC CL A), valued at $8.10M, representing 0.61% of its reported portfolio and ranking #32.

Has Boxer Capital Management, LLC been buying or selling CTNM?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in CTNM. The position peaked in Q2 2026 at 494.00K shares.

Which other funds hold CTNM?

Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, GREAT POINT PARTNERS LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.